LOS ANGELES ― A common dilemma in neurosurgery is whether to immediately replace the bone flap in the skull after surgical treatment of an acute subdural […]

A novel experimental drug for early Parkinson’s disease (PD) yielded similar results as commercially available pramipexole extended-release (ER) but with significantly less daytime sleepiness, a new […]

The FDA  has approved the first treatment that takes a genetics-based approach to slowing or stopping the progression of a rare form of ALS, the debilitating […]

The vast majority of melatonin gummies sold in the US may contain up to 347% more melatonin than is listed on the label, and some products […]

BOSTON – A new subcutaneous system for infusing levodopa-carbidopa continuously over 24 hours to control Parkinson’s disease met its primary and secondary endpoints in a double-blind, double-dummy […]

High-dose vitamin D in patients with relapsing, remitting multiple sclerosis (RRMS) does not prevent relapse, results from a randomized control trial show. However, at least one […]

Noninvasive tests performed in midlife may help identify people who are at risk of late-onset epilepsy (LOE), a new study suggests. New data from the Framingham […]

Editor’s note: Find the latest long COVID news and guidance in Medscape’s Long COVID Resource Center. BOSTON — The neurologic symptoms of long COVID appear to be explained […]

The investigational agent eplontersen (Ionis Pharmaceuticals/AstraZeneca) halted neuropathy disease progression and improved neuropathy impairment and quality of life for patients with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) […]